search
Back to results

TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study) (TACTICS)

Primary Purpose

Hypercholesterolemia

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
stage-matched intervention
framing effects intervention
attention placebo intervention
Sponsored by
Narrows Institute for Biomedical Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypercholesterolemia focused on measuring cholesterol, diabetes, adherence

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults with diabetes
  • LDL greater than or equal to 100
  • Cholesterol-lowering drug therapy for > 6 months
  • A working telephone
  • At least 2 primary care visits in the past 1.5 years

Exclusion Criteria:

  • Poor short-term survival (< 1 year)
  • Inability to understand English
  • Recent major surgery (< 3 months)
  • Patients temporarily in the area
  • Inability to provide consent

Sites / Locations

  • VA New York Harbor Healthcare System, NY and BK Campuses

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

stage-matched intervention

framing effects intervention

attention placebo intervention

Arm Description

Transtheoretical Model-based stage-matched intervention

counseling based on prospect theory

counseling about general health topics

Outcomes

Primary Outcome Measures

LDL control
medication adherence

Secondary Outcome Measures

diet adherence
exercise adherence

Full Information

First Posted
January 5, 2010
Last Updated
April 1, 2014
Sponsor
Narrows Institute for Biomedical Research
search

1. Study Identification

Unique Protocol Identification Number
NCT01043354
Brief Title
TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)
Acronym
TACTICS
Official Title
TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)
Study Type
Interventional

2. Study Status

Record Verification Date
April 2014
Overall Recruitment Status
Completed
Study Start Date
September 2008 (undefined)
Primary Completion Date
June 2012 (Actual)
Study Completion Date
June 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Narrows Institute for Biomedical Research

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: This is a randomized controlled trial (RCT) of two novel behavioral interventions to enhance treatment adherence and improve low-density lipoprotein cholesterol (LDL) in diabetes. Among adults with diabetes, high LDL greatly increases their risk for cardiovascular disease (CVD). Despite the proven efficacy of LDL control(<100 mg/dL) in preventing CVD, the control rate is low. Poor adherence to treatment(diet, exercise and medication) is the main reason for this poor control. Aims: This study will test two telephone-delivered interventions, a Transtheoretical stage-matched intervention (SMI) and a Prospect theory-based framing effects intervention (FEI). The investigators hypothesize that both SMI and FEI will be more effective in improving LDL control than an attention placebo intervention (API) at 6 months. SMI and FEI will also be more effective in increasing adherence to medications, diet and exercise than API at 6 months. Methods: The investigators will recruit 246 adults with diabetes and high LDL despite being on medications. Key outcomes are adherence to diet, exercise and medication, and LDL control. The interventions will be standardized and fidelity of intervention maintained. Using a blinded RCT the investigators will test the effect of SMI and FEI compared to API on LDL control and adherence. All analyses will be intent to treat. Significance: This project will provide important information to improve diabetes-related behavior and lead to the implementation of novel interventions for lowering LDL in primary care settings among adults with diabetes. It may also provide the scientific rationale to use such approaches to control other risk factors in diabetes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypercholesterolemia
Keywords
cholesterol, diabetes, adherence

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
247 (Actual)

8. Arms, Groups, and Interventions

Arm Title
stage-matched intervention
Arm Type
Experimental
Arm Description
Transtheoretical Model-based stage-matched intervention
Arm Title
framing effects intervention
Arm Type
Experimental
Arm Description
counseling based on prospect theory
Arm Title
attention placebo intervention
Arm Type
Active Comparator
Arm Description
counseling about general health topics
Intervention Type
Behavioral
Intervention Name(s)
stage-matched intervention
Intervention Description
6 monthly tailored telephone-delivered counseling sessions of transtheoretical model-based counseling
Intervention Type
Behavioral
Intervention Name(s)
framing effects intervention
Intervention Description
6 monthly telephone-delivered counseling sessions based on prospect theory
Intervention Type
Behavioral
Intervention Name(s)
attention placebo intervention
Intervention Description
6 monthly counseling sessions about general health topics
Primary Outcome Measure Information:
Title
LDL control
Time Frame
6 months
Title
medication adherence
Time Frame
6 months
Secondary Outcome Measure Information:
Title
diet adherence
Time Frame
6 months
Title
exercise adherence
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults with diabetes LDL greater than or equal to 100 Cholesterol-lowering drug therapy for > 6 months A working telephone At least 2 primary care visits in the past 1.5 years Exclusion Criteria: Poor short-term survival (< 1 year) Inability to understand English Recent major surgery (< 3 months) Patients temporarily in the area Inability to provide consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sundar Natarajan, MD, M.Sc.
Organizational Affiliation
VA New York Harbor Healthcare System
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA New York Harbor Healthcare System, NY and BK Campuses
City
New York
State/Province
New York
ZIP/Postal Code
10010
Country
United States

12. IPD Sharing Statement

Learn more about this trial

TACTICS (Targeting Adherence to Cholesterol-lowering Therapy to Improve Control Study)

We'll reach out to this number within 24 hrs